GeoPolitics Pulse

The Heartbeat of World events

After temporary reprieve, Advanz Pharma’s liver med Ocaliva loses marketing nod in Europe

by ·

Europe, European Union, EU, European Commission, EC Ocaliva is a second-line treatment for the autoimmune disease primary biliary cholangitis …Read More

Related posts:

  1. ADVANZ PHARMA secures temporary suspension of the European Commission decision …
  2. European Commission Revokes Obeticholic Acid (Ocaliva) CMA for Primary Biliary Cholangitis
  3. Sanctioned Russian Oil Tankers Get Temporary Reprieve in India | OilPrice.com
  4. ADVANZ PHARMA’s response to the reversal of the suspension – GlobeNewswire
  5. Ziosoft Receives European Union MRD Certifications for Lung and Liver Surgical Planning …